Wolters Kluwer Survey: Over Two-Thirds of U.S. Physicians Have Changed Their Mind, Now Viewing GenAI as Beneficial in Healthcare
Forty percent ready to use GenAI this year at point of care but 89% of doctors need content source transparency for confident adoption
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240416378499/en/
Generative AI (GenAI) in healthcare: Growing physician enthusiasm. A survey commissioned by
Physicians, however, are wary of which GenAI tools they would be comfortable using, with 91% of respondents saying they need to know the GenAI sourced materials were created by doctors and medical experts before using it in clinical decisions. Similarly, 89% report they need vendors to be transparent about where information came from, who created it, and how it was sourced.
“Physicians are open to using generative AI in a clinical setting provided that applications are useful and trustworthy,” said Dr.
Transformative tech: GenAI viewed as helping to save time and optimize care teams
With healthcare facing challenges with staffing shortages and burnout, physicians see manybenefits to applying GenAI in the care continuum. When asked how GenAI could support decision making or improve interactions at the point-of-care:
- Four in five (81%) physicians say GenAI will improve care team interaction with patients.
- Over half believe GenAI will save them 20% or more time.
- Over two-thirds (68%) say it can save time by quickly searching medical literature.
- Three in five (59%) say it can save time by summarizing data about patients from the electronic health record (EHR).
- Only 3% do not believe GenAI will improve interactions with patients.
Doctors and patients diverge on GenAI in care
Comparing results of this survey with a Wolters Kluwer survey of
Doctors set high transparency and content source standards for GenAI guidelines
Physicians’ responses reflect a landscape that is still developing clear guidance or policies on using GenAI. Over a third (37%) say there are currently no guidelines in place at their organizations about using GenAI while almost half (46%) say they don’t know of any guidelines.
Still, physicians have concerns about the source of content and want transparency. For the majority of physicians (58%), the number one most important factor when selecting a GenAI tool is knowing the content it is trained on was created by medical professionals.
Nine out 10 (89%) report they would be more likely to use GenAI in clinical decisions if the vendor was transparent about where the information came from, who created it, and how it was resourced. Knowing that the technology is from a well-known, trusted company was also a priority: 76% would be more comfortable using GenAI knowing it came from established vendors in the healthcare sector.
A responsible approach to Clinical GenAI
For more information, download the Generative AI in Healthcare: Growing Physician Enthusiasm Survey Executive Summary
For more information about Wolters Kluwer, please visit: www.wolterskluwer.com
1 This survey, commissioned by
About Wolters Kluwer
Wolters Kluwer (EURONEXT: WKL) is a global leader in information, software solutions and services for professionals in healthcare; tax and accounting; financial and corporate compliance; legal and regulatory; corporate performance and ESG. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with technology and services.
Wolters Kluwer reported 2023 annual revenues of €5.6 billion. The group serves customers in over 180 countries, maintains operations in over 40 countries, and employs approximately 21,400 people worldwide. The company is headquartered in Alphen aan den Rijn,
For more information, visit www.wolterskluwer.com, follow us on LinkedIn, Facebook, YouTube and Instagram.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240416378499/en/
Media
Director,
+1 (781) 392-2411
andre.rebelo@wolterskluwer.com
Source: